Kodiak Gas Services (NYSE:KGS) Bolsa

Kodiak Gas Services

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to primarily fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.

Kodiak Gas Services Inc

Kingspan Group PLC

KINGSPAN GROUP UNSP/ADR by Kingspan Group plc.

KINGMAN MINERALS LTD by Kingman Minerals Ltd.

Kingman Minerals Ltd

UBS analyst Kevin Caliendo maintains Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) with a Neutral and raises the price target from $16 to $17.

News

Price Target

Analyst Ratings

ALHC

UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $17

UBS analyst Joseph Spak maintains Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) with a Neutral and raises the price target from $58 to $66.

APTV

UBS Maintains Neutral on Aptiv, Raises Price Target to $66

UBS analyst Gavin Parsons maintains Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) with a Neutral and raises the price target from $120 to $155.

UBS Maintains Neutral on Howmet Aerospace, Raises Price Target to $155

UBS analyst Karl Chalabala maintains Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Buy and raises the price target from $21 to $22.

FOLD

UBS Maintains Buy on Amicus Therapeutics, Raises Price Target to $22

UBS analyst Peter Grom maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Neutral and raises the price target from $60 to $62.

UBS Maintains Neutral on Estee Lauder Cos, Raises Price Target to $62

UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Buy and raises the price target from $160 to $170.

UBS Maintains Buy on Cardinal Health, Raises Price Target to $170

UBS analyst Kevin Caliendo maintains CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) with a Neutral and raises the price target from $67 to $71.

UBS Maintains Neutral on CVS Health, Raises Price Target to $71

UBS analyst Eliana Merle maintains Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a Buy and lowers the price target from $78 to $70.

MRNA

UBS Maintains Buy on Moderna, Lowers Price Target to $70

Casey's General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) has outperformed the market over the past 5 years by 9.81% on an annualized basis producing an average annual return of 24.45%. Currently, Casey's General Stores has a market capitalization of $16.70 billion. 
Buying $100 In CASY: If an investor had bought $100 of CASY stock 5 years ago, it would be worth $299.50 today based on a price of $458.65 for CASY at the time of writing.
<h3>Casey's General Stores's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746225012_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CASY

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

UBS analyst Eliana Merle maintains Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) with a Buy and raises the price target from $441 to $458.

MDGL

UBS Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $458

UBS analyst Joshua Spector maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Neutral and raises the price target from $21 to $22.

UBS Maintains Neutral on Olin, Raises Price Target to $22

UBS analyst Kevin Mcveigh maintains Paylocity Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) with a Neutral and raises the price target from $195 to $200.

PCTY

UBS Maintains Neutral on Paylocity Holding, Raises Price Target to $200

UBS analyst Trung Huynh maintains Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with a Buy and lowers the price target from $1100 to $1050.

UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050

UBS analyst Chris Kuntarich maintains Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) with a Buy and raises the price target from $400 to $500.

DUOL

UBS Maintains Buy on Duolingo, Raises Price Target to $500

UBS analyst Stephen Ju maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Neutral and lowers the price target from $138 to $137.

ABNB

UBS Maintains Neutral on Airbnb, Lowers Price Target to $137

UBS analyst Stephen Ju maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and lowers the price target from $253 to $249.

AMZN

UBS Maintains Buy on Amazon.com, Lowers Price Target to $249

Citigroup analyst Jason Bazinet maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $78 to $85.

RBLX

Citigroup Maintains Buy on Roblox, Raises Price Target to $85

Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIO#NYSE">BIO</a>) with a Buy and lowers the price target from $400 to $350.

Citigroup Maintains Buy on Bio-Rad Laboratories, Lowers Price Target to $350

Citigroup analyst Ygal Arounian maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Neutral and raises the price target from $30 to $32.

Citigroup Maintains Neutral on Wayfair, Raises Price Target to $32

Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.10) by 160 percent. This is a 116.22 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $79.95 million which beat the analyst consensus estimate of $73.23 million by 9.18 percent. This is a 6.16 percent increase over sales of $75.31 million the same period last year.

Earnings

Earnings Beats

VNCE

CORRECTION: Vince Holding Q4 Adj. EPS $0.06 Beats $(0.10) Estimate, Sales $79.95M Beat $73.23M Estimate

Press Releases

Kodiak Gas Services Announces Pricing of Upsized Offering of Common Stock by Selling Stockholder

Kodiak Gas Services Announces Public Offering of Common Stock by Selling Stockholder

Kodiak Gas Services Announces Pricing of Underwritten Offering of 5,500,000 Shares of Common Stock by Selling Stockholder

Commodities

Offerings

EQT completes public offering of common stock of Kodiak Gas Services

Kodiak Gas Services Announces Quarterly Dividend and Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Schedule

EQT completes sale of common stock of Kodiak Gas Services pursuant to Rule 144

Kodiak Gas Services Announces 2024 Schedule K-1 Investor Tax Packages for CSI Compressco LP Are Available Online

Kodiak Gas Services Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance

Kodiak Gas Services Breaks Ground on State-of-the-Art Facilities in Midland and Pecos

Kodiak Gas Services Announces Increased Quarterly Dividend and First Quarter 2025 Earnings Release and Conference Call Schedule

ProFrac Holding Corp. - Class A Common Stock

ProFrac Holding

Atlas Energy Solutions

Aris Water Solutions, Inc. Class A Common Stock

Aris Water Solutions

Archrock

Baker Hughes

ChampionX

Flowco Holdings Inc. Class A Common Stock

Flowco Holdings

TechnipFMC

Halliburton

Helix Energy Solutions Group, Inc. Common Stock

Helix Energy Solns Gr

Innovex International

Liberty Energy

National Energy Services Reunited Corp - Ordinary Shares

National Energy Services

Oceaneering International, Inc. Common Stock

Oceaneering International

Solaris Energy Infrastructure, Inc. Class A Common Stock

Solaris Energy

Schlumberger

Tidewater

Tenaris

USA Compression Partners, LP Common Units Representing Limited Partner Interests

Comments

Kodiak Gas Services

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL